The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
The company is developing treatments that restore gut bacteria in people struggling with a range of diseases.
In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.
New molecule for imaging calcium in neurons reduces crosstalk from neighboring neurons.
Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.
Research projects will harness the power of artificial intelligence to positively impact human health.
A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.
Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.
MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.
Manufacturability is key to producing a widely available, affordable vaccine.
/
47